-
Chelsea beat Brighton in seven-goal thriller to extend Alonso's perfect start
-
At least seven die in ferry capsize off Northern Cyprus; 23 missing
-
Zambia's opposition leader charged with treason
-
In-form Marc Marquez wins Aragon MotoGP Grand Prix
-
Marc Marquez wins Aragon MotoGP Grand Prix
-
At least six die in ferry capsize off Northern Cyprus
-
Robinson rocks Pakistan again as England eye series win at Lord's
-
Niamey back to normal after soldier mutiny
-
Nepal rescuers advance towards trapped tunnel workers
-
King Haakon joins Norway memorials for Harald
-
Grisly search for missing as Nepal morgues overflow, burials begin
-
NASA launches Roman telescope on cosmic mapping mission
-
Barcelona's Yamal getting back to 'top level': Flick
-
Van Dijk wants Gakpo to stay at Liverpool amid Man City interest
-
Dutch federation calls for football summit without Infantino
-
Five-wicket Abbas has Lord's landmark as Pakistan set 389 to win second Test
-
Ron’s Honky Tonk Residency Revives UK Country Music in Bermondsey
-
Tadej Pogacar Out of Vuelta a Espana with Broken Collarbone and Concussion
-
Chelsea sign Argentina 'stopper Martinez from Villa
-
Iceland votes 'No' to resuming EU talks
-
Norway's churches hold services to late King Harald
-
Berlin Literary Guide: Book Launches, Festivals, and Readings Through August
-
Walmart Agrees to $50 Million Settlement Over Opioid Prescription Allegations
-
Nepal rescuers drill through debris towards trapped tunnel workers
-
Soundcore Liberty 5 Pro Review: Call Quality Redefines Value in Wireless Earbuds
-
Manhunt in Switzerland after fatal rave shooting
-
Lexus ES Review: Electric ES 350e Falls Short in Luxury Saloon Segment
-
'No' camp seen winning Iceland's EU referendum
-
Vietnamese coffee farmers ride China's durian wave
-
Nepal flood survivors return to ruins to salvage memories
-
Venezuela says retains 'sovereignty' in US oil deal
-
Killing of Palestinian children and teens by Israel surges in West Bank
-
NASA's Roman telescope set to launch on cosmic mapping mission
-
Educators keep 9/11 memory alive for next generation, 25 years on
-
Data center backlash scrambles US midterm politics
-
Venezuelans view US oil deal with doubt, hope
-
Emotional Federer inducted into tennis Hall of Fame
-
Gobena and Jepchirchir power to Sydney Marathon victories
-
Hovland takes solo lead as McIlroy surges at Tour Championship
-
Iceland in suspense after close EU vote
-
Djokovic 'prepared' for US Open bid for history
-
Wallabies hold on for victory in Argentina
-
Atletico down Sevilla to go top of La Liga
-
Juve notch second straight win, Fiorentina's centenary party falls flat
-
US deports right-wing provocateur Milo Yiannopoulos
-
Rybakina eases injury fears ahead of US Open
-
Niger junta says it is back in control after soldiers' mutiny
-
Djokovic kicks off latest Grand Slam quest under US Open lights
-
Erasmus calls Rennie barbs over Springbok scrumming 'nonsense'
-
'Sorry' De Zerbi won't panic after Spurs shambles
Bausch Health to Announce Third Quarter 2025 Results on October 29
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
W.Nelson--AT